<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">University of Southern California School of Medicine</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">W</forename><surname>King Engel</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">University of Southern California School of Medicine</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Massimiliano</forename><surname>Mirabella</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">University of Southern California School of Medicine</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">426A92C54437FC8E85E1A17C22E4D0D2</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-04-26T03:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>In this review, the main emphasis is on new advances concerning sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Polymyositis and dermatomyositis are reviewed briefly. Hypotheses are presented regarding the possible cause and significance of abnormally accumulated -amyloid protein, two other epitopes of -amyloid precursor protein, hyperphosphorylated 't, a.1-antichymotrypsin, ubiquitin, and prion protein in sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Because most of those proteins are also accumulated at the neuromuscular junction, "junctionalization" of other muscle fiber nuclei is a possibility. Attention is given to the fact that vacuolated muscle fibers in hereditary inclusion-body myopathy may represent early changes because they are virtually free of congophilic amyloid deposit but, like sporadic inclusion-body myositis, contain large accumulations of 13-amyloid protein and prion.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sporadic inclusion-body myositis and hereditary inclusion-body myopathy</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sporadic inclusion-body myositis</head><p>Sporadic inclusion-body myositis (s-lBM) is the most common muscle disease beginning in patients 50 years of age and older <ref type="bibr">[2,4•,S,6•]</ref>. Predominantly in men, distal and proximal muscle weakness is present. There is a characteristic thinning of the forearms, which is associated with weakness of the finger extensors, flexors, or both, and prominent involvement of the quadriceps. The slowly progressive course usually leads to severe disability and eventually to respiratory muscle weakness. Dysphagia is fairly common; it can appear during the muscle weakness or precede it <ref type="bibr" target="#b9">[7]</ref>. In older patients with dysphagia, IBM should be in the differential diagnosis.</p><p>Even though patients often show poor or no response to prednisone and other immunosuppressive treatments, in our experience occasional patients have significant improvement with prednisone (20 to 60 mg as a single dose on alternate days), oral cyclophosphamide (2 mg/kg/d) or total-body irradiation (Engel and Askanas, Unpublished data). This benefit can persist for 6 months to 5 years (and sometimes longer), but normal strength is not restored. Similar benefit was recently reported by others <ref type="bibr" target="#b10">[8,</ref><ref type="bibr" target="#b11">9]</ref>, but drug doses and duration of improvement were not stated in one report <ref type="bibr" target="#b11">[9)</ref>. Treatment with intravenous immunoglobulin was reported to be beneficial in three of four s-IBM patients <ref type="bibr" target="#b12">[10]</ref>; however, this finding was not confirmed by another trial in seven patients <ref type="bibr" target="#b13">[11]</ref>.</p><p>The light microscopic pathologic features of s-IBM include degrees of mononuclear cell inflammation that vary from abundant in the early stages to little or none in the later stages; muscle fibers with one or several irregular vacuoles that are usually red rimmed (on Engel-Gomori trichrome staining <ref type="bibr" target="#b14">[12]</ref>), which are more common in the middle and later stages; and atrophic angu-</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p>Al}-P-amyloid protein; PAPP-p-amyloid precursor protein; h-lBM-hereditary inclusion-body myopathy; IBM-inclusion-body myositis; mRNA-messenger RNA; s-lBM-sporadic inclusion-body myositis.</p><p>lar muscle fibers, which are histochemically dark with panesterase and NADH-tetrazolium reductase reactions and considered to be indicative of a denervation component <ref type="bibr">[4•</ref>]. The inflammatory cells are similar to those in polymyositis, being mainly CDS+ cytotoxic T cells <ref type="bibr">(3.. ,13)</ref>. In both diseases, macrophages comprise approximately 20% to 30%, of the cells surrounding or invading nonnecrotic muscle fibers; within necrotic fibers, they make up 80% of the invading cells 113).</p><p>Because red-rimmed vacuoles are sometimes present in only a few muscle fibers and can be very small, s-IBM, especially in its early stages, can be difficult to distinguish from polymyositis by routine histochemistry. In general, s-IBM is probably underdiagnosed, more so in some countries 114). To help differentiate s-IBM from polymyositis by light microscopy of freshfrozen sections, we suggest 1) Engel-Gomori trichrome staining for red-rimmed vacuoles; 2) fluorescence-enhanced Congo red 115.. ) or crystal-violet staining for small bits of amyloid within some vacuolated fibers; 3) alkaline phosphatase staining for connective tissue (typically negative or low in s-IBM but usually prominent in polymyositis) (Askanas and Engel, Unpublished data); and 4) immunocytochemical staining for ubiquitin, for which commercial antibody can be used 116).</p><p>The ultrastructural diagnostic criterion for s-IBM is the presence of cytoplasmic "twisted tubulofilaments" of 15 to 21 nm in external diameter </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hereditary inclusion-body myopathy</head><p>Hereditary inclusion-body myopathy (h-IBM) is included in this review because it has striking morphochemical phenotype similarities to s-IBM, as described later. h-IBM is inherited either as an autosomal recessive or an autosomal dominant trait 14   </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unusual aspects of sporadic inclusion-body myositis and hereditary inclusion-body myopathy pathology</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Speculations on the pathogenesis</head><p>Considerations about the as yet uncertain pathogenesis of s-IBM and h-IBM include the following two general possibilities. The first is that one "master gene" is activated, which in tum directly or indirectly activates the genes for all the accumulated proteins. The master gene could also diminish genetic expression of an enzyme or other factor important in protein disposal to enhance further the accumulation of the characteristic proteins. The master gene could be switched on (or a gene inhibiting it could be switched ofO in s-IBM by an environmental factor, such as a virus, and in h-IBM by the inherited abnormality.</p><p>The second possibility is that one protein is accumulated first because of excessive synthesis (excessive synthesis, ie, excessive mRNA, is known for PAPP <ref type="bibr">[43••]</ref> and prion <ref type="bibr">[Sarkozi et al.</ref>, Unpublished data)), decreased disposal, or both. Accumulation of this first protein leads, in some manner, to accumulation of the others, perhaps by the first protein's 1) acting as a transcription-activating factor for them via a common enhancer or promoter region on their genes, 2) binding to them (eg, apolipoprotein E and t are known to bind to AP tn vitro <ref type="bibr" target="#b57">[47,</ref><ref type="bibr">481)</ref> or 3) impairing their catabolism.</p><p>The postsynaptic neuromuscular junction of a normal innervated mature muscle fiber is a morphologically and chemically specialized region induced, directly or indirectly, by the influence of the innervating motor neuron axon tips. At the human neuromuscular junction, there is a persistent normal accumulation of proteins that are abnormally accumulated in s-IBM and h-IBM, ie, PAPP <ref type="bibr" target="#b59">[49)</ref>, prion [SO•], &lt;X1-antichymotrypsin <ref type="bibr" target="#b62">[51)</ref>, apolipoprotein E <ref type="bibr" target="#b63">[52)</ref>, fibroblast growth factor (37), transforming growth factor-P <ref type="bibr" target="#b51">[42)</ref>, ubiquitin (531, and the well-known nicotinic acetylcholine receptor and its 43-kD protein. Accumulation of PAPP mRNA is also increased at the neuromuscular junction <ref type="bibr">[43.</ref>. l. Nonjunctional regions of mature human innervated fibers do not have accumulation of these proteins. At the normal neuromuscular junction some, or possibly all, of the characteristic "junctional proteins" are presumably continually synthesized under the influence of their activated genes in the special "junctional nuclei" of the muscle fiber. We propose that the orchestrated synthesis of the junctional proteins could be due to the persistent exuberant action (within the junctional muscle nuclei) of either a) a putative master gene conducting "junctionalization," and/orb) a "junctionalizing enhancer/promoter region" common to genes of the accumulated junctional proteins. In s-lBM and h-IBM, the accumulation of junctional proteins in nonjunctional regions of vaculoated muscle fibers could be caused by a similar exuberance of that master gene (or enhancer/promoter region) being provoked in nonjunctional nuclei, ie, a junctionalization of them by an environmental (eg, viral) or hereditary factor mimicking the action of the still unidentified neurogenic junctionalizing influence at the neuromuscular junction.</p><p>In regenerating human muscle fibers, a similar increase in the levels of some of the IBM proteins occurs, but to a lesser degree and in a more homogeneous pattern. This increase may be provoked by a partially similar gene activation mechanism. For example, in nonjunctional regions of human regenerating muscle fibers in vivo, PAPP immunoreactivity is expressed moderately, in a diffuse pattern (54) (unlike the strong multifocal pattern in IBM vacuolated muscle fibers). The accumulation of PAPP mRNA is also increased in these regenerating fibers <ref type="bibr" target="#b65">[54,</ref><ref type="bibr">551</ref>, and PAPP mRNA is present in human myotubes in tissue culture, where it becomes downregulated during their development [551.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuromuscular diseases: muscle</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuropathy in sporadic inclusion-body myositis and hereditary inclusion-body myopathy</head><p>Transverse sections of every s-IBM and h-IBM biopsy specimen contain small angular muscle fibers that have dark staining with panesterase and NADH-tetrazolium reductase reactions and are considered to be indicative of denervation <ref type="bibr">(4•,56)</ref>; on electromyography, some patients have a neurogenic pattern 157) (any denervation of muscle fibers can result from a neurogenic or myogenous process <ref type="bibr" target="#b69">[58)</ref>). In h-lBM, the histochemical evidence of denervation sometimes vastly predominates over vacuolated fibers or other definitely myopathic features (Engel and Askanas, Unpublished data), such that we are tempted to call it "hereditary inclusionbody myopathy-neuropathy." In s-IBM, we propose that the neuropathic component may fail to respond to immunosuppression.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Possible relevance to the pathogenesis of Alzheimer's disease</head><p>Because the same proteins that accumulate within the s-IBM and h-IBM muscle fibers accumulate in the brain in sporadic and hereditary Alzheimers's disease, the muscle diseases might have pathogenic analogies to Alzheimer's disease, and knowledge of one might help to elucidate the other. Within each organ disease group, the sporadic and hereditary forms are morphochemical phenocopies of each other. Between the two muscle and brain disease groups, perhaps the sporadic diseases involve parallel pathogenic mechanisms (possibly provoked by a viral process, an autoimmune process, or both) and the two hereditary subgroups involve similar mechanisms eventuating in the accumulated proteins.</p><p>One protein, prion, is not accumulated in the brains of patients with Alzheimer's disease but it is in the brains of patients with sporadic and hereditary prion diseases [591. In the prion brain diseases, the level of prion mRNA is not increased; instead, a unique non-mRNA mechanism of prion accumulation has been proposed [591. The muscle fibers of the IBMs are different from those of the prion brain diseases because they do have increased mRNA accumulation, suggesting that their increased level of prion protein is related to exuberance of the normal mRNA mechanisms of prion accumulation, which occurs normally in muscle fibers at neuromuscular junctions and during regeneration (Askanas et al., Unpublished data).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Polymyositis</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and pathologic considerations</head><p>Polymyositis is usually a sporadic disease that affects women more commonly than men (1,2,3 Therefore, to monitor the status of the liver, we routinely also measure levels of serum y-glutamyl transpeptidase (GGTP) because it reflects leakage from the liver but not muscle.) In polymyositis, electromyography shows a pattern of brief duration, small-amplitude, overly abundant motor unit action potentials that are often polyphasic <ref type="bibr" target="#b71">[60)</ref>, with some fibrillations. Diagnostic histochemical features of the muscle biopsy specimen include various degrees of muscle fiber necrosis and regeneration; perivascular and endomysial mononuclear cell infiltration; and increased amounts of endomysial and perimysial connective tissue, which typically is very positive with alkaline phosphatase <ref type="bibr" target="#b69">[58)</ref>.</p><p>(Normally connective tissue is alkaline phosphatase negative, as it can be very early in polymyositis.) This alkaline phosphatase positivity probably reflects activated or proliferating fibroblasts. It is greater than in other myopathies with proliferated connective tissue, such as Duchenne's muscular dystrophy, which usually contains no or very little alkaline phosphatase positivity. We suspect that the amount of connective tissue alkaline phosphatase positivity in polymyositis and in dermatomyositis reflects the more rapid pace of fibroblast proliferation. Immunosuppressive treatment can rapidly reduce or eliminate inflammatory cells in polymyositis muscle biopsy specimens, but not their alkaline phosphatase positivity. Alkaline phosphatase positivity is also a feature of some activated/regenerative muscle fibers <ref type="bibr" target="#b72">[61)</ref>; however, it is not diagnostic because it is seen in regenerative fibers of any neuromuscular disease <ref type="bibr" target="#b72">[61)</ref>. Thus, regenerative/proliferative properties of both muscle fibers and fibroblasts are associated with alkaline phosphatase positivity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Muscle biopsy immunopathology</head><p>The mononuclear cell infiltrates in polymyositis muscle biopsy specimens consist of T cells, macrophages, and to a lesser degree, B cells. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Autoantibodies</head><p>Various circulating autoantibodies were reported in polymyositis 13 Antibodies against a signal recognition particle also occur in a few polymyositis patients who have a disease that is very severe and responds poorly to treatment 1721. No evidence indicates a direct pathogenic role of the circulating antibodies in polymyositis 171]; they may represent epiphenomena <ref type="bibr" target="#b1">[1)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary</head><p>In summary, idiopathic polymyositis is an immune-mediated disorder of unknown cause. The factors that induce inflammatory response in the muscle tissue need to be identified. It is not known whether an altered muscle fiber itself instigates the inflammatory response</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and pathologic considerations</head><p>Adult dermatomyositis is more prevalent in women.</p><p>A reddish or purplish skin rash often precedes muscle weakness. Dermatomyositis is sometimes associated with systemic sclerosis, mixed connective tissue disease, other systemic autoimmune diseases, and occasionally malignancies 11,3-J. Conversely, all 12 biopsied patients with lupus erythematosus had inflammatory myopathy histochemically typical of dermatomyositis 1741.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Muscle biopsy immunopathology</head><p>Mononuclear cell inflammation is often present in the dermatomyositis muscle biopsy specimen. Its degree varies among patients, and some very weak, untreated patients have virtually no inflammation 13.. ,741. Relatively few muscle fibers are surrounded or invaded by lymphocytes, which are mainly in the interstitial and perivascular areas. Unlike in polymyositis, the infiltrates contains a high proportion of B cells and CD4+ T cells 13.. J. Histochemically delineated perifascicular muscle fiber atrophy, involving both type I and type II muscle fibers, is a characteristic morphologic feature of dermatomyositis but is also seen in scleroderma 174) and lupus erythematosus 174). Alkaline phosphatase positivity of the connective tissue can also be prominent in dermatomyositis muscle.</p><p>The treatment of dermatomyositis has been summarized elsewhere (1,3.. ,73). Recently, intravenous immunoglobulin has been reported to be beneficial 175•], but one would like to find a less expensive longterm treatment. Intravenous immunoglobulin treatment does, however, raise interesting points about the possible mechanisms of benefit 175•].</p><p>Because angiopathy is well established in dermatomyositis muscle, dermatomyositis has been considered a primary vascular disease. The accumulation of complement, mainly C3, in muscle capillaries may be the earliest abnormality in dermatomyositis; it is usually followed by the involvement of the larger blood vessels (1,3.. ,76,771. Immune-mediated intramuscular an-</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuromuscular diseases: muscle</head><p>giopathy is considered to be responsible for capillary thickening, stenosis, and loss, causing ischemia that results in muscle fiber necrosis and perifascicular atrophy. Deposits of IgG and IgM in muscle blood vessels are common <ref type="bibr">[1,3.. ,76,77]</ref>, but the factors leading to complement activation and to complement and immunoglobulin deposition are not known. Although a humoral immune response directed against intramuscular blood vessels appears to play the important role in the pathogenesis of dermatomyositis, it is not yet known why the blood vessels of the muscles and skin are selectively targeted. Are these blood vessels "innocent bystander" victims of a humeral antibody attack intended for something else, such as a virus or bacterium not in vessels (eg, due to a shared antigen)? Or have some muscle or skin blood vessels been made "foreign" by an exogenous influence, making the ensuing humeral attack on them "normal"? When the first pathogenic steps are learned, more rational treatment might be devised.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>Even though s-lBM, polymyositis, and dermatomyositis have various degrees of mononuclear cell inflammation in muscle biopsy specimens, the pathogenesis of each may be different. All three seem to have a dysimmune pathogenesis, possibly are of viral etiology, and probably involve genetic susceptibility factors of the patients. As more insight is gained into the molecular biology of each pathogenesis and etiology, better treatments should be able to be devised.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>, and those of very advanced age 130,311; in these conditions, abnormal accumulation of AP is considered to be partially due to increased generation of PAPP and partly to abnormal processing of it 130,311.) Because injected ubiquitin was reported to induce amyloidogenesis 1321, it is of interest whether the increased ubiquitin in s-lBM and h-lBM muscle fibers 1331 can enhance amyloid deposits there.Whereas some of the Congophilic amyloid deposits are located deep within the muscle fiber, others are subjacent to the plasmalemma, and some appear to have come out of the muscle fiber 14•). None of our 12 patients with several other vacuolar myopathies, including acid-maltase deficiency, hypokalemic periodic paralysis, and undefined types, had Congophilic amyloid deposits. As in s-lBM, abnormal muscle fibers in some of these disorders can have increased acid phos-I, and prion protein messenger RNA(Sarkozi et al., Unpublished data) are also increased within vacuolated s-IBM and h-IBM muscle fibers, indicating that the abnormal accumulation of the corresponding proteins is caused, at least partly, by locally increased generation.</figDesc><table><row><cell>In both s-IBM and h-IBM vacuolated muscle fibers,</cell></row><row><cell>prion, PAPP, apolipoprotein E, ubiquitin, fibroblast</cell></row><row><cell>growth factor, transforming growth factor-P, and a.1-an-</cell></row><row><cell>tichymotrypsin are abundantly present. In h-IBM, hy-</cell></row><row><cell>perphosphorylated t is present in only 24% of the vac-</cell></row><row><cell>uolated muscle fibers that are immunoreactive with the</cell></row><row><cell>other excessive proteins {17.. ). Thus, paucity of both</cell></row><row><cell>Congophilic amyloid and hyperphosphorylated t in the</cell></row><row><cell>h-IBM vacuolated muscle fibers is a subtle quantitative</cell></row><row><cell>distinction from s-IBM. In our h-IBM patients, double-</cell></row><row><cell>fluorescence studies revealed some vacuolated mus-</cell></row><row><cell>cle fibers that were AP immunoreactive but Congo red</cell></row><row><cell>negative 117.. ,291; we conclude that in these fibers,</cell></row><row><cell>Intracellular amyloid deposits</cell></row><row><cell>Amyloid denotes the physical configuration of any pro-</cell></row><row><cell>tein aggregated in P-pleated sheets that stains with</cell></row><row><cell>Congo red (ie, is Congophilic) and is metachromat-Ultrastructural localizations</cell></row><row><cell>ically pink with crystal-violet. A number of different Gold immunolocalization of the characteristic proteins, including the P-amyloid protein (AP) part of Alzheimer proteins and prion protein in vacuolated P-amyloid precursor protein (PAPP), have the propen-IBM muscle fibers (Table 1) strikingly resembles their sity to self-aggregate in this way. Congo red-positive localization in abnormal brain. First, as in Alzheimer's amyloid was demonstrated in vacuolated IBM mus-brain, AP is immunolocalized to 6-to 10-nm amyloid-cle fibers by Mendell et al. 127), and we confirmed like fibrils, amorphous structures, and flocculomem-this finding with thioflavin S and crystal-violet stain-branous material, in each of which it closely colo-ing 128,29). Our new method of fluorescence-enhanced calizes with ubiquitin; C-and N-terminal epitopes of</cell></row><row><cell>Congo red positivity 115.. 1, which enables identification PAPP are present on amorphous structures and floc-</cell></row><row><cell>of even very tiny amyloid deposits, reveals amyloid in culomembranous material but not on the 6-to 10-nm</cell></row><row><cell>virtually 100% of s-IBM vacuolated fibers 115.. ,17.. ). fibrils (51. However, the intracellular paired helical fila-</cell></row><row><cell>However, fluorescence-enhanced Congo red positivity ments, in both IBM muscle and brain, do not contain</cell></row><row><cell>of the vacuolated fibers occurs in only 30% of our pa-either PAPP or AP immunoreactivity [1&lt;)-•,29,45). Sec-tients with autosomal recessive h-IBM (and in them, in ond, hyperphosphorylated t is present only in paiJ'ed only 30% to 400/4 of their vacuolated fibers) 14•,17••]. helical filaments It7••], and third, apolipoprotein E is</cell></row><row><cell>Unresolved questions about the Congophilic amyloid present mainly on paired helical filaments (36•).</cell></row><row><cell>in s-IBM relate to its chemical nature and origin, the Prion protein is localized to paired helical filaments type of subcellular structure containing it, and its ini-flocculomembranous and amorphous structures, and tial location in the muscle fiber. In IBM muscle fiber, the Congophilic amyloid might or might not be par-tially due to APl28,29), which is a 39-to 42-residue the 6-and 10-nm amyloid-like fibrils (where it colocal-izes with Al3) 134-J.</cell></row><row><cell>polypeptide part of PAPP 1301. (AP is the major com-</cell></row><row><cell>ponent of amyloid fibrils in blood vessels and senile</cell></row></table><note>plaques in the brain of Alzheimer's disease, Down's syndrome, Dutch hereditary cerebrovascular amyloido-sisphatase staining indicative of increased lysosomal activity, and this increased staining is very prominent in acid-maltase deficiency. Because such biopsy specimens do not have Congophilic amyloid, it is unlikely that the amyloid deposits in s-lBM result from a nonspecific disturbance of lysosomal function. In our experience to date, the only non-IBM muscle disorder with intramyofiber Congophilia is oculopharyngeal muscular dystrophy, in which we found it in two of two patients (Unpublished data). Abnormal muscle fibers in oculopharyngeal muscular dystrophy can also have increased ubiquitin deposition 1331. Whether intramyofiber Congophilia will be convincingly demonstrated in any other muscle disease remains to be seen.Abnormal accumulation of characteristic Alzheimer proteins and prionWithin the vacuolated muscle fibers of s-lBM and h-IBM, we have identified abnormal accumulations of prion protein[34.. ] and several proteins typically accumulated in the brains of patients with Alzheimer's disease, ie, AP 128,291, N-and C-terminal epitopes of PAPP[19.. I, cx.i-antichymotrypsin 135•1, hyperphosphorylated tll 7.. 1, apolipoprotein E 136•1, fibroblast growth factor (371, and ubiquitin {10,331. The accumulation of ubiquitin<ref type="bibr" target="#b47">[38,</ref>391 and PAPP 138,<ref type="bibr" target="#b49">40)</ref> in S-IBM fibers has been confirmed by others. Nicotinic acetykholine receptor, its 43-kD associated protein<ref type="bibr" target="#b50">(41)</ref>, and transforming growth factor-P (42) are also abnormally accumulated in IBM vacuolated muscle fibers. The total ensemble of proteins that we have found to be accumulated excessively in s-IBM and h-IBM muscle fibers appears to be unique for these diseases in our experience to date. We cannot be certain whether this will remain true as more muscle diseases are studied in similar detail. In oculopharyngeal muscular dystrophy, two of the proteins are accumulated, ubiquitin 133,381 and PAPP 1401 (Askanas et al., Unpublished data). Levels of PAPP messenger RNA, (mRNA) encoding PAPP containing the Kunitz-type proteinase inhibitor sequence 143.. AP is not in P-pleated sheets (as is the case with AP in Congo red negative diffuse plaques of Alzheimer's brain disease 144).) Perhaps these h-IBM fibers are in an earlier stage of the pathologic process (as was also suggested for Alzheimer's diffuse plaques). Two other speculations are 1) that when the t epitope known to be in IBM paired helical filaments[17••]  is antigenically intact and in a configuration that is immunohistochemically demonstrable with the antibody, it might be at least partly responsible for Congophilia and 2) that AP accumulation in the p-pleated sheet configuration might lead to induction of the hyperphosphorylated t antigenic material. Moreover, nicotinic acetylcholine receptor is localized to paired helical filaments arid to paired helical filaments and to flocculomembranous and amorphous structures, but the 43-kD protein.•is strongly localized to paired helical filaments only [4l'] (Table1).</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 1 .</head><label>1</label><figDesc>Subcellular localization of P-amyloid precursor protein epitopes, ubiquitin, prion, hyperphosphorylated t, n-acetyld1oline receptor, and 43-kD Denotes presence of the element and (-) denotes absence.IIAPP-P-amyloid precursor protein.When autosomal recessive Persian Jewish h-IBM muscle is cultured aneurally, it expresses a partial IBM phenotype, in the form of vacuoles and increased PAPP accumulation (Askanas and Mcferrin, Unpublished data). When innervated by motor neurons from cocultured fetal rat spinal cord to produce rather well differentiated muscle fibers, h-IBM fibers from two other patients showed even more of the IBM phenotype, ie,</figDesc><table><row><cell cols="2">protein in inclusion-body myositis muscle</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Nicotinic</cell><cell></cell></row><row><cell></cell><cell>13-Amyloid</cell><cell>N-terminal</cell><cell>C-terminal</cell><cell></cell><cell></cell><cell>Hyperphos-</cell><cell></cell><cell>acetylcholine</cell><cell>43-kD</cell></row><row><cell>Structure</cell><cell>protein</cell><cell cols="6">j3APP epitope j3APP epitope Ubiquitin Prion phorylated t Apolipoprotein E</cell><cell>receptor</cell><cell>protein</cell></row><row><cell>Paired helical filaments 6-to 10-nm amyloid-like fibrils Amorphous structures Floculomembranous material</cell><cell>-+ + +</cell><cell>--+ +</cell><cell>--+ +</cell><cell>+ + + +</cell><cell>+ + + +</cell><cell>+ ---</cell><cell>+ +/-+/-+/-</cell><cell>+ -+/-+/-</cell><cell>+ ---</cell></row><row><cell cols="3">(+) Tissue culture of hereditary inclusion-body</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>myopathy muscle</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>paired helical filaments[26,461.  Because these characteristic features have been reproduced in cultured h-IBM muscle, this culture model can provide genetically and morphologically abnormal living tissue that is readily accessible for a wide range of molecular studies, including gene transfer (to date, we have transferred three different genes in an adenovirus vector to our cultured human muscle fibers).</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc>Polymyositis usually causes symmetric proximal muscle weakness, sometimes associated with muscle pain and tenderness. Rarely, polymyositis can be accentuated focally, eg, as forearm swelling and soreness.</figDesc><table><row><cell>Without treatment, the disease is progressive, often</cell></row><row><cell>leading to severe disability. Respiratory failure can oc-</cell></row><row><cell>cur due to respiratory muscle weakness and sometimes</cell></row><row><cell>pulmonary fibrosis. The serum creatine kinase level is</cell></row><row><cell>elevated and reflects leakage from only skeletal mus-</cell></row><row><cell>cle fibers or heart, and creatine kinase-MB elevation</cell></row><row><cell>can reflect leakage from regenerating skeletal muscle</cell></row><row><cell>fibers or heart. (Elevations in the levels of the serum</cell></row><row><cell>enzymes aspartate aminotransferase (SGOU, alanine</cell></row><row><cell>aminotransferase (SGPU, and lactate dehydrogenase</cell></row><row><cell>(LDH) are not organ specific-they can reflect leak-</cell></row><row><cell>age from skeletal muscle, heart, or liver cells.</cell></row></table><note>••). Occasionally, more than one case occurs within a family, and other autoimmune disorders are not unusual among relatives 13.. ).</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0">© 1994 Current Science ISBN 1-85922-678-7 ISSN 1350-7540</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: • Of special interest •• Of outstanding interest</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Clinical, Immunopathologic, and Therapeutic Consideration of Inflammatory Myopathies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Neuropharmacol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="327" to="351" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Inflammatory Myopathies: A Review</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Heffner</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol F.xp Neurol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="339" to="350" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The Polymyositis and .. Dennatomyositis Syndromes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Q</forename><surname>Banker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Myology</title>
				<editor>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Franzini-Armstrong</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>McGraw-Hill</publisher>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page" from="1335" to="1383" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Detailed review of clinical, pathological, and possible pathogenic mechanisms in polymyositis and dermatomyositis by outstanding researchers in the field</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Conceptual review of the newest scientific advances concerning sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note>New Advances in Inclusion-Body • Myositis</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Inclusion-Body Myositis: Clinical and Histopathological Features of 36 Patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Beyenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zierz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jerusalem</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Invest</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="351" to="361" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Myology</title>
				<editor>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Franzini-Armstrong</surname></persName>
		</editor>
		<meeting><address><addrLine>New York, McGraw-Hill</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page" from="1384" to="1398" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Detailed review of clinical and pathological findings in inclusionbody myositis</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Inclusion-Body Myositis Presenting Solely as Dysphagia</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Riminton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Parkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Donaldson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1241" to="1243" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Therapy for Myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Oddis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="742" to="748" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Inclusion-Body Myositis: Analysis of 32 Cases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Sayers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Calabrese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1385" to="1389" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main">Treatment of Inclusion-Body Myositis With High-Dose Intravenous Immunoglobulin. Neurology</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Soueidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="876" to="879" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inclusion-Body Myopathy: Treatment With Intravenous Immunoglobulin</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">A130</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Rapid Examination of Muscle Tissue: An Improved Trichrome Method for Fresh-Frozen Biopsy Sections</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="919" to="923" />
			<date type="published" when="1963">1963</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Monoclonal Antibody Analysis of Mononuclear Cells in Myopathies: II. Phenotypes of Autoinvasive Cells in Polymyositis and Inclusion Body Myositis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="209" to="215" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inclusion Body Myositis: An Underdiagnosed Condition?</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Hopkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lowe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="147" to="151" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Description of a new and easy method illustrating the use of the green fluorescence and Texas-red filters to enhance visualization of even very small Congo-red positive amyloid deposits</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1265" to="1267" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note>Enhanced Detection of •• Congo-Red-Positive Amyloid Deposits in Muscle Fibers of Inclusion-Body Myositis and Brain of Alzheimer Disease Using Fluorescence Technique</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Immunocytochemical Localization of Ubiqultin in Inclusion Body Myositis Allows Its Light-Microscopic Distinction From Polymyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="460" to="461" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Twisted Tubulofilaments of Inclusion-Body Myositis Muscle Resemble Paired Helical Filaments of Alzheimer Brain and Contain Hyperphosphorylated Tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Detailed description of the hyperphosphorylated t localization in inclusion-body myositis. First illustration that cytoplasmic twisted tubulofilaments of inclusion-body myositis resemble paired helical filaments of the brain in Alzheimer</title>
		<imprint/>
	</monogr>
	<note>s patients</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Light-and Elcctronmicn&gt; scopic Localization of Amyloid Protein in Muscle Biopsies of Patients With Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Patbol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Abnormal Accumulations .. of Amyloid Precursor Epltopes in Muscle Fibers of Inclusion Body Myosltis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">3-amyloid protein epitopes of P-amyloid precursor protein are abnormally localized in vacuolated muscle fibers of inclusionbody myositis. Light and electron-microscopic studies</title>
		<author>
			<persName><forename type="first">C-</forename></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
		<author>
			<persName><forename type="first">!</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Mckee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Johnston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Familial Inclusion Body Myositis (IBM) Mimics Facioscapulohumeral Dystrophy</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">302</biblScope>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Familial Inclusion Body Myositis: Evidence for Autosomal Dominant Inheritance</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sujansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="897" to="902" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Familial Inclusion Body Myosltis Among Kurdish-Iranian Jews</title>
		<author>
			<persName><forename type="first">R</forename><surname>Massa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shonbridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="519" to="522" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title/>
		<author>
			<persName><surname>Idiopathic</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gadoth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hadar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ben-David</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Vacular My-&quot; apathy Sparing The Quadriceps</title>
				<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="217" to="232" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Twenty-two Jewish patients belonging to 15 families (11 of them from Iran and three of possible Iranian origin) with common consanguinity were described. Clinically, the most characteristic feature was distal and proximal muscle weakness with characteristic sparing of the quadriceps muscle. The morphological picture resembles inclusion-body myositis</title>
		<imprint/>
	</monogr>
	<note>but there was no inflammation</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<author>
			<persName><forename type="first">F</forename><surname>Hentati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Hamida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Tome</forename><forename type="middle">F</forename><surname>Oueslati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fardeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Hamida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Familial Inclusion Body Myosltls&quot; Sparing the Quadriceps With Asymptomatic Leukoencephalopathy in a Tunisian Kindred</title>
				<imprint>
			<date type="published" when="1991">1991</date>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">422</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Familial Myopathy With Changes Resembling Inclusion Body Myositis and Pcriventricular Leukoencephalopathy: A New Syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuzniecky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="page" from="102S" to="1037" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Hereditary Neuromuscular Disorder With Inclusion Body Myosltls-Llke Filamentous Inclusion: Clinical, Pathological, and Tissue Culture Studies (Abstract)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chevallay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page">120</biblScope>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Amyloid Filaments in Inclusion Body Myositis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Glenner GG: j&gt;Amy-loid Protein lmmunoreactivity In Muscle of Patients With Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="560" to="561" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Light-and Electronmicroscopic Localization of j&gt;Amyloid Protein in Muscle Biopsies of Patients With Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Normal and Abnormal Biology of the j&gt;Amyloid Precursor Protein</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="489" to="517" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The Molecular Pathology of Alzheimer&apos;s Disease</title>
				<imprint>
			<date type="published" when="1991">1991</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="487" to="497" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Alzheimer&apos;s Disease Brain-Derived Ubiquitin Has AmyloJd.Enhancing Factor Activity: Behavior of Ubiquitin During Accelerated Amyloidogcnesis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Alizadeh-Khiavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Normand</forename><forename type="middle">J</forename><surname>Chronopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ali-Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="280" to="286" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Immunolocalization of Ubiquitin in Muscle Biopsies of Patients With Inclusion Body Myositis and Oculopharyngeal Muscular Dystrophy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="73" to="76" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">A: Prion Protein Is Abnonnally Accumulated in Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="2S" to="28" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">Vacuolated muscle fibers of eight s-lBM and four h-IBM patients contained strong deposits of prion protein immunoreactivity within their vacuoles. By immunoelectron microscopy, prion protein was present on amorphous material, 6-to •10-nm amyloid-like fibrils</title>
		<imprint/>
	</monogr>
	<note>and paired helical filaments</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Strong lmmunon:activity • of «rAntichyrnotrypsin Colocalizes With j&gt;Amyloid Protein and Ubiquitin in Vacuolated Muscle Fibers of Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="378" to="382" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title level="m" type="main">Vacuolated muscle fibers of nine s-IBM and one h-lBM patients contained large and small a1-ACT immunoreactive cytoplasmic inclusions. a1-ACT immunoreactivity colocalized with -amyloid protein ubiquitin immunoreactivities</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Apolipoprotein E Immunoreactive Deposits in Inclusion-Body Muscle Diseases</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">•</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="364" to="365" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Vacuolated muscle fibers of s-and h-lBM contain strong immunoreactivity of ApoE. By electronmicroscopy, ApoE is localized to the cytoplasmic twisted tubulofilaments</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Twisted Tubulofilaments (TfFs) in Inclusion Body Myositis (IBM) Muscle Contain Fibroblast Growth Factor (FGF) and Its Receptor</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">30</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Ubiquitin and j&gt;Amyloid-Protein in Inclusion-Body Myositis (IBM), Familial IBMlike Disorder and Oculopharyngeal Muscular Dystrophy: An Immunocytochemlcal Study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="283" to="291" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Ubiquitin Expression in Inclusion-Body Myositis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Albrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bilbao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol I.ab Med</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="789" to="793" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Rimmed Vacuoles of Inclusion Body Myosltls and Oculopharyngeal Muscular Dystrophy Contain Amyloid Precursor Protein and Lysosomal Markers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Villanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lubke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Six</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ceuterick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-J</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">603</biblScope>
			<biblScope unit="page" from="343" to="347" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Muscle Nicotinic Acetylcholine Receptor (nAChR) and Its Associated Protein 43 Kd (43K) Are Highly Accumulated in Vacuolated Muscle Fibers (VMFs) of Inclusion Body Myositis (IBM) [Abstract)</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Froehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">31</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Transforming Growth Factor-Beta-I (fGFS-1) Is Abnormallly Accumulated in Vacuolated Muscle Fibers of Sporadic Inclusion-Body Myositis (s-lBM) and Hereditary Inclusion-Body Myopathy (h-lBM)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Alvarez RB: .. j&gt;Amyloid Precursor Protein mRNA Is Increased in Inclusion-Body Myositis Muscle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="81S" to="88" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<monogr>
		<title level="m" type="main">In vacuolated muscle fibers of eight sporadic and two hereditary inclusion-body myositis patients, messenger RNA encoding (3-amyloid precursor protein containing KPI motif was increased. The increase of -amyloid precursor protein messenger RNA colocalized with abnormally accumulated epitopes of (3-amyloid precursor protein by immunocytochemistry. APP messenger RNA is also increased in the neuromuscular junction</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Diffuse Type of Senile Plaques in the Brains of Alzheimer-Type Dementia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Morimatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shoji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Harigaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="113" to="119" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Ultrastructural Localization of j&gt;Amyloid, &apos;t and Ubiquitin Epitopes In Extracellular Neurofibrillary Tangles</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tabaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cammarata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maucardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Manetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Autilio-Gambetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gambetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="2089" to="2102" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Characteristic Filamentous Inclusions Reproduced in Cultured Innervated Muscle Fibers From Patients With Familial &quot;Inclusion Body Myositis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tome</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page">178</biblScope>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Evangelista Sobel IR: Role of Tau in the Polymerization of Peptides From j&gt;Amy-lold Precursor Protein</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Caputo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Sygowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">597</biblScope>
			<biblScope unit="page" from="227" to="232" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Binding of Human Apolipoprotein E to Synthetic Amyloid p Peptide: Isoform-Specific Effects and Implications for Late-Onset Alzheimier Disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-M</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Salvesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pericak-Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci US A</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="8098" to="8102" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Strong lmmunoreactivity of j&gt;Amyloid Precursor Protein, Including the j&gt;Amyloid Protein Sequence</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Human Neuromuscular Junctions. Neuroscl Lett</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="96" to="100" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Prion • Protein Is Strongly Immunolocalized at the Postsynaptic Domain of Human Normal Neuromuscular Junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tome</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="111" to="114" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<monogr>
		<title level="m" type="main">Prion protein was localized at the postsynaptic domain of human neuromuscular junctions, where it closely colocalized with a-bungarotoxin, three epitopes of ji-amyloid precursor protein (including P-amyloid protein), desmin, ubiquitin, and dystrophin</title>
		<imprint/>
	</monogr>
	<note>Neuromuscular diseases: muscle</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Engel WK: a1-Antlchymotrypsin Is Strongly Immunolocalized at Normal Human and Rat Neuromuscular Junctions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synapse</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="28" to="283" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Immunocytochemical Localization of Apolipoprotein E (ApoE) in Inclusion Body Myositis (IBM) [Abstract)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">347</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">lmmunocytochemlcal Localization of Ubiqultin at Human Neuromuscular Junctions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathol Appl Neurohiol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="232" to="236" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Expression of Amyloid Precursor Protein, Prlon, Acetylcholine Receptor and Their mRNAs in Human Muscle FiMS Regenerating in Vivo</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Pathol</title>
		<imprint>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Expression of jl-Amyloid Precursor Protein Gene Is Developmentally Regulated in Human Muscle Fibers In Vivo and In Vitro</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Inclusion Body Myosltls, An Inflammatory Disease?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Cardiomiol Ill</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="111" to="116" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Inclusion Body Myosltis (IBM): Myopathy or Neuropathy?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1109" to="1114" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Integrative Histochemical Approach to the Defect of Duchenne Muscular Dystrophy</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Pathogenesis of the Human Muscular Dystrobies Edited by Rowland LP</title>
				<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>American Elsevier Publishing Co</publisher>
			<date type="published" when="1977">1977</date>
			<biblScope unit="page" from="277" to="309" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Molecular Biology of Prlon Diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="page" from="1515" to="1522" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Brief, Small, Abundant Motor-Unit Action Potentials</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="173" to="176" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Alkaline Phosphatase-Positive Abnormal Muscle Fibers of Humans</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Histochem Cytochem</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="55" to="57" />
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Analysis of T Cell Receptor Repertoire of Muscle-Infiltrating T Lymphocytes in Polymyositis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mantegazza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andreeta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bernasconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Baggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oksenberg</forename><forename type="middle">.</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><surname>Simoncini 0</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cornelio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steinman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="2880" to="2886" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<monogr>
		<title level="m" type="main">Detailed study of T-cell receptor abnormalities in polymyositis applying molecular biology techniques</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Polymyositis Mediated by T Lymphocytes That Express the Gamma/Delta Receptor</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Harper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="page" from="877" to="881" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Polymyositis and Dcrmatomyositis: No Persistence of Enterovirus or Enchephalomyocarditls Virus RNA in Muscle</title>
		<author>
			<persName><forename type="first">Pjh</forename><surname>Jongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Zoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beaumont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wjg</forename><surname>Melchers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lba</forename><surname>Van De Pune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jmd</forename><surname>Galarna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dts</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="575" to="578" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">HI• rose S-1: HI.A-DP Positive T Cells in Patients With Polymyositls/Dermatomyosltis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kanai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tokano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okumura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="77" to="79" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Expression in Synovial Fluid T Lymphocytes in Rheumatoid Arthritis: Cell Cycle Analysis of HI.A-DP Positive T Cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hirose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okumura</surname></persName>
		</author>
		<author>
			<persName><surname>Hi.A-Dr</surname></persName>
		</author>
		<author>
			<persName><surname>Antigen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rbeumatol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="18" to="23" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Expression of lmmactlvc Major Hlstocompatibillty Complex Products in Human Skeletal Muscles</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pouliot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="64" to="72" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">MHC Class I, MHC Class U and Intercellular Adhesion Molecule-I (ICAM-1) Expression in lnflam. matory Myopathles</title>
		<author>
			<persName><forename type="first">E</forename><surname>Banoccioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gallucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Scuderi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Servidei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tonali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="166" to="172" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Humoral Immunity in Polymyosltis/Dermatomyosltis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Targoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="116S" to="123S" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Drug Therapy of the Idiopathic Inflammatory Myopathles: Predictors of Response to Prednisone, Azathloprine, and Methotrcxate and a Comparison of Their Efficacy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Joffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Targoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="379" to="387" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Treatment of Neuromuscular Diseases</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jberapy for Neurologtc Dtsorders</title>
		<editor>Wiederholt WC</editor>
		<imprint>
			<biblScope unit="volume">1982</biblScope>
			<biblScope unit="page" from="51" to="101" />
			<publisher>J. Wiley Sons</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<monogr>
		<title level="m" type="main">Muscle Biopsies in Neuromuscular Diseases. Pediatr Clin North Am</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1967">1967</date>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="963" to="995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions As Treatment for Dcrmatomyositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Illa</forename><forename type="middle">I</forename><surname>Dambrosia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Soueidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">•</forename><surname>Dp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Otero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Dinsmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mccrosky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<date type="published" when="1993">1993. 1993-2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<monogr>
		<title level="m" type="main">Double-blind, placebo-controlled study of 15 patients with derrnatomyositis. Eight patients who were receiving intravenous immune globulin improved, while seven patients on placebo did not. Highdose intravenous immune globulin is an effective treatment for dermatomyositis</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Vascular Deposits of Immunoglo ulin and Complement in Idiopathic Inflammatory Myopathy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Whitaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="333" to="338" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Persistence of Enterovirus RNA in Muscle Biopsy Samples Suggests That Some Cases of 77</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Bowles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Bayston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rjm</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Archard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Rammohan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="page" from="329" to="334" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note>Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Chronic Fatigue Syndrome Result From a Previous Inflam-65. matory Viral Myopathy</title>
	</analytic>
	<monogr>
		<title level="j">J Med</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="145" to="160" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Absence of Persistent lnfec. tion With Enteroviruses in Muscles of Patients With Inflammatory Myopathles</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="219" to="222" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">King</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Massimiliano</forename><surname>Mirabella</surname></persName>
		</author>
		<imprint>
			<biblScope unit="page">637</biblScope>
		</imprint>
		<respStmt>
			<orgName>MD, University of Southern California School of Medicine, Depanment of Neurology</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Lucas</forename><surname>South</surname></persName>
		</author>
		<author>
			<persName><surname>Avenue</surname></persName>
		</author>
		<imprint>
			<pubPlace>Los Angeles, CA 90017-1912, USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
